Industry Newshealthcare stockspharmaceuticalsjohnson johnsonmarket rotation
Jim Cramer Notes Johnson & Johnson Resilience
3.8
Relevance Score
Jim Cramer said Johnson & Johnson can thrive in a weak economy, citing steady demand for toothpaste, medicines and medical devices, but cautioned that its recent stock rally may be moving too fast. The article, republished from Insider Monkey and Yahoo Finance, contrasts J&J's defensive appeal with a promotional pitch for an AI stock claiming up to 10,000% upside.


